Partnerships
NeoNeuro Receives Investment from ADDF
NeoNeuro Receives Investment from ADDF NeoNeuro announced today that the Alzheimer’s Drug Discovery Foundation (ADDF) invested in the company through
July 10, 2020
News
Read More »
Papers
Review Paper: Blood Based Diagnostics of Alzheimer’s Disease.
Blood Based Diagnostics of Alzheimer’s Disease. Early detection of Alzheimer’s disease (AD) relies on identifying reliable biomarkers in blood. In
June 3, 2019
Papers
Aptamers as Biomarkers for Neurological Disorders
Aptamers as Biomarkers for Neurological Disorders. Proof of Concept in Transgenic Mice Blood-based diagnostics provide a minimally invasive way to
January 5, 2018
Partnerships
NeoNeuro Partners with the INSIGHT Cohort
NeoNeuro Partners with the INSIGHT Cohort NeoNeuro SAS has entered into a collaboration under the leadership of Professor Harald Hampel
November 10, 2017
Partnerships
NeoNeuro Collaborates with the AIBL Study
NeoNeuro Collaborates with the AIBL Study NeoNeuro SAS is pleased to announce a collaboration with the Australian Imaging, Biomarker &
June 5, 2017
Grants
BPI France Grant Awarded to NeoNeuro
NeoNeuro Awarded a New BPI France Grant NeoNeuro recently received a new grant from BPI France to advance research on
December 12, 2015
Grants
BPI France Grant
NeoNeuro Receives BPI France Grant NeoNeuro has received support from BPI France under the PIA-1 program to advance the use
September 25, 2015